Xiao Zhou — Harbin Medical University

Area of research

Internal Medicine · Cancer Research

Research interest

Research focused on Liraglutide and Endocrinology, with related work in Gene knockdown, Hsp70, PI3K/AKT/mTOR pathway. Notable publications include 'Long non‑coding RNA TMPO‑AS1 promotes tumor progression via sponging miR‑140‑5p in breast cancer', 'Glutamine promotes Hsp70 and inhibits α-Synuclein accumulation in pheochromocytoma PC12 cells', and 'Liraglutide alters DPP4 in the circumvallate papillae of type 2 diabetic rats'.

Recent publications

Long non‑coding RNA TMPO‑AS1 promotes tumor progression via sponging miR‑140‑5p in breast cancer

Experimental and Therapeutic Medicine 2020cited by 12position: middledoi

Glutamine promotes Hsp70 and inhibits α-Synuclein accumulation in pheochromocytoma PC12 cells

Experimental and Therapeutic Medicine 2017cited by 12position: middledoi

Liraglutide alters DPP4 in the circumvallate papillae of type 2 diabetic rats

Journal of Molecular Endocrinology 2016cited by 5position: middledoi

PI3K/Akt/mTOR signal transduction pathway and tumor

Int J Immunol 2016cited by 0position: firstdoi

Expression of NUCB2/nesfatin-1 in the taste buds of rats

Endocrine Journal 2015cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Internal Medicine · Cancer Research →